Key facts
- Medical Photonics’s last known valuation is $790K (Dec 2024).
- It has raised $230K; the latest was Early Stage VC ($230K) in Dec 2024.
- Notable investors include Nottingham Technology Ventures, University of Nottingham.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Medical Photonics
- ·The full record, as it builds
Funding rounds
No funding rounds for Medical Photonics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medical Photonics
Operator of a medical diagnostics company intended to enhance patient care. The company offers integrated optical sensing technology with accurate, repeatable measurement capability and tools built for use in clinical workflows to create advanced optical fiber-based systems, enabling healthcare professionals and medical device developers to gather detailed patient data and support better decision-making in patient care.
- Sector
- Healthcare
- HQ
- Nottingham, United Kingdom
- Founded
- 2024
- Employees
- 6
- Website
- medicalphotonics.co.uk/
- Ownership
- Privately Held (backing)
Medical Photonics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medical Photonics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medical Photonics in its N-PORT filings yet. We sweep new filings monthly.